Revision history of "Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab" (Q81151636)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 August 2024

20 April 2023

18 October 2022

19 July 2022

6 July 2022

26 May 2022

12 January 2022

30 September 2021

28 June 2020

6 January 2020